1. Home
  2. KRP vs WVE Comparison

KRP vs WVE Comparison

Compare KRP & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRP
  • WVE
  • Stock Information
  • Founded
  • KRP 2013
  • WVE 2012
  • Country
  • KRP United States
  • WVE Singapore
  • Employees
  • KRP N/A
  • WVE N/A
  • Industry
  • KRP Oil & Gas Production
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRP Energy
  • WVE Health Care
  • Exchange
  • KRP Nasdaq
  • WVE Nasdaq
  • Market Cap
  • KRP 1.1B
  • WVE 915.6M
  • IPO Year
  • KRP 2017
  • WVE 2015
  • Fundamental
  • Price
  • KRP $13.53
  • WVE $7.11
  • Analyst Decision
  • KRP Hold
  • WVE Strong Buy
  • Analyst Count
  • KRP 5
  • WVE 16
  • Target Price
  • KRP $17.20
  • WVE $20.19
  • AVG Volume (30 Days)
  • KRP 455.1K
  • WVE 1.8M
  • Earning Date
  • KRP 11-06-2025
  • WVE 11-11-2025
  • Dividend Yield
  • KRP 12.67%
  • WVE N/A
  • EPS Growth
  • KRP N/A
  • WVE N/A
  • EPS
  • KRP N/A
  • WVE N/A
  • Revenue
  • KRP $312,566,668.00
  • WVE $93,946,000.00
  • Revenue This Year
  • KRP $9.34
  • WVE N/A
  • Revenue Next Year
  • KRP $2.80
  • WVE $6.85
  • P/E Ratio
  • KRP N/A
  • WVE N/A
  • Revenue Growth
  • KRP N/A
  • WVE N/A
  • 52 Week Low
  • KRP $10.98
  • WVE $5.28
  • 52 Week High
  • KRP $16.99
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • KRP 46.41
  • WVE 41.44
  • Support Level
  • KRP $13.38
  • WVE $6.91
  • Resistance Level
  • KRP $13.83
  • WVE $7.24
  • Average True Range (ATR)
  • KRP 0.29
  • WVE 0.31
  • MACD
  • KRP 0.02
  • WVE 0.06
  • Stochastic Oscillator
  • KRP 30.19
  • WVE 58.69

About KRP Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: